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Available online 22 April 2008The second helix in the C-terminal domain of retroviral capsid (CA) protein functions as the site of
dimerization between subunits in capsid assembly and is believed to participate in a unique interface between
Gag molecules in immature particles. This study reports isolation of two substitutions in the dimerization
helix of Rous sarcoma virus CA protein that have the ability to suppress lethal defects in core maturation
imposed by alterations to the major homology region (MHR) motif just upstream. Together with two
previously published suppressors, these deﬁne an extended region of the dimerization helix that is unlikely to
contribute directly to CA–CA contacts but whose assembly-competence may be strongly affected by
conformation. The broad-spectrum suppression and temperature-sensitivity exhibited by some mutants
argues that they act throughmodulation of protein conformation. These ﬁndings provide important biological
evidence in support of a signiﬁcant conformational change involving the dimerization helix and the MHR
during maturation.
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Major homology regionIntroduction
A highly conserved motif named the major homology region (MHR)
lies within the CA region of the Gag structural proteins of orthore-
troviruses and a diverse collection of other reverse transcribing
elements like hepadnaviruses, the yeast retrotransposon Ty3, LINE
elements, and telomeric retrotransposons of Drosophila (Craven et al.,
1995; McClure, 1991; Orlinsky et al., 1996; Pardue et al., 2005;Wills and
Craven, 1991; Zlotnick et al., 1998). Outside of the MHR the amino acid
sequences of CA proteins are quite diverse, yet all share a common
structural organization with two independently-folded α-helical
domains, the N-terminal domain (NTD) and C-terminal domain (CTD)
(Fig. 1A, B) (Berthet-Colominas et al., 1999; Campos-Olivas et al., 2000;
Cornilescu et al., 2001; Gamble et al., 1996; Gamble et al., 1997; Gitti
et al., 1996; Jin et al., 1999; Khorasanizadeh et al., 1999; Kingston et al.,
2000; Momany et al., 1996; Mortuza et al., 2004; Tang et al., 2002;
Worthylake et al., 1999).The MHR spans approximately 20 amino acids
of the CTD, speciﬁcally the strand immediately following the inter-
domain linker through the turn and ﬁrst α-helix of the domain (Fig. 1B).), rcraven@psu.edu
University College of Medicine,
l rights reserved.Conserved hydrophobic residues of the MHR contribute to the core of
the folded domain, while polar ones form a hydrogen-bond network
that links together the strand and ﬁrst two α-helices (Kingston et al.,
2000; Worthylake et al., 1999).
The evolutionary conservation of the MHR predicts a critical role of
the motif in one or more stages of the viral life cycle and the retro-
transposition process. Extensive mutagenesis of the MHR in the Rous
sarcoma virus (RSV, a member of the Alpharetrovirus genus), other
retroviruses and the Ty3 retrotransposon has demonstrated a range of
phenotypes caused by alteration to the conserved residues. The
observed effects on Gag function include interference with normal
Gag protein membrane targeting or binding, distortion of the morphol-
ogy of released particles or a complete loss of immature particle
assembly (Alin and Goff, 1996; Cairns and Craven, 2001; Craven et al.,
1995; Mammano et al., 1994; Orlinsky et al., 1996; Strambio-de-Castillia
andHunter,1992; von Schwedler et al., 2003;Willemset al.,1997).Other
substitutions allow the normal formation and release of particles but
cause a subsequent failure of the structures to mature normally to form
functional core structures (Alin and Goff,1996; Cairns and Craven, 2001;
Craven et al., 1995; Mammano et al., 1994; Orlinsky et al., 1996;
Strambio-de-Castillia and Hunter, 1992; von Schwedler et al., 2003;
Willems et al.,1997). This suggests overlapping roles of themotif in both
the Gag functions needed to build an immature particle and in the
creation of the capsid shell from the CA subunits that are subsequently
released upon protease activation at or near the time of provirion
release. A total of twenty-ﬁve substitutions introduced at the most
192 P.M. Lokhandwala et al. / Virology 376 (2008) 191–198conserved positions of the RSV MHR motif were unable to identify
particular sub-domains of the region that are critical for one part of the
assembly pathway but not the other.
A structural study of the dimerized CTD of the CA of human
immunodeﬁciency virus type 1 (HIV-1) has provided amodel thatmayFig.1. (A) Alignment of the RSV and HIV CA CTD sequences. Position of α-helices is marked by
of suppressors in the dimerization helix is bolded. (B) Position of the MHR residues and their
PDB ﬁles 1EM9 and 1EOQ for the NTD and the CTD respectively and connecting them by a do
examined in this study (in blue) and the residues where suppressor mutations map (in red
model of RSV CTD dimer. The model was created by superimposing the RSV CTD structu
Worthylake et al., 1999). Structural alignment was done using the program SARF2 (Alexandhelp explain how the MHR contributes to Gag assembly. Relaxation of
the bend between the MHR and the adjacent dimerization helix by
deletion of a single residue allowed the CTD to dimerize in a “domain-
swapped” arrangement creating an extensive anti-parallel interface
(Ivanov et al., 2007). Several of the conservedMHR residues, instead ofstring of H's. MHR is underlined, with the identical and similar residues bolded. Position
second-site suppressors in the RSV CA structures. Ribbon diagramwas created using the
tted line. The two domains are not drawn to scale. The side-chains of the MHR residues
) are shown. (C) Position of the second-site suppressor mutations on the presumptive
re (PDB ﬁle 1EOQ) onto the HIV-1 CTD dimer (PDB ﬁle 1A43) (Kingston et al., 2000;
rov and Fischer, 1996).
Fig. 2. Conﬁrmation of suppression activity of the R185W and the F193L mutations.
(A) R185W suppressor mutation rescues the infectivity of the D155Y MHR mutant.
(B) F193L suppressor mutation rescues the infectivity of the E162Q MHR mutant.
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interactions across the dimer interface that would appear to explain
their conservation. Because of the structural homology of this domain-
swapped HIV CTD dimer to the dimer of SCAN interaction domains of
cellular proteins that are evolutionarily related to Gag (Ivanov et al.,
2005; Kingston and Vogt, 2005), it was predicted that this arrange-
ment exists between Gag proteins in immature virions. This proposed
mode of dimerization is consistent with the loss of normal Gag
assembly observed in many MHR mutants. However, a recently
published cryo-electron tomographic study of immature HIV could
neither conﬁrm nor refute its presence (Wright et al., 2007). Thus,
additional biological evidence beyond the loss-of-function studies
available to date will be necessary in validating its importance.
The means by which the MHR residues contribute to formation of
the mature core structure is less clear. The accepted model for the
mature capsid shell formation posits that a hexameric lattice is formed
via interactions between the α-1, α-2 and α-3 helices of neighboring
NTDs and that inter-hexamer associations are accomplished via a
dimeric interface involving the α-2 helix (dimerization helix) of the
CTD in parallel alignment (Briggs et al., 2003; Ganser et al., 1999;
Ganser-Pornillos et al., 2007; Li et al., 2000;Mayo et al., 2003;Mortuza
et al., 2004; Yeager et al., 1998). Analysis of 2-D crystals of the murine
leukemia virus, HIV and RSV proteins dictate that the same packing
mode likely applies to all orthoretroviruses (Barklis et al., 1998; Ganser
et al., 2003; Mayo et al., 2002). Additional inter-domain contacts in
which the NTD docks with the CTD of a neighbor appear to form only
during maturation and are a hallmark of the ﬁnal assembled capsid
(Ganser-Pornillos et al., 2007; Lanman et al., 2003; Lanman et al.,
2004). The MHR residues do not contribute directly to any of these
known CA–CA interfaces.
The isolation of genetic suppressors of crippling CAmutations by our
laboratory has proven to be a novel means of identifying interactions
between distant residues of CA that are important for normal core
assembly and function. Beginning with RSV viruses bearing MHR
mutations that prevent formation of a functional core structurewithout
obvious alterations of Gag functions, four second-site suppressors were
isolated that could restore part or all of the infectiouspotential (Bowzard
et al., 2001). Two suppressors fell in theNTD, predicting the involvement
of an NTD–CTD interaction at some point in assembly or maturation of
the particle (Bowzard et al., 2001). Such an interface in mature HIV
virions, but not immature particles, has since been conﬁrmed by
biochemical and structural studies (Ganser-Pornillos et al., 2007;
Lanman et al., 2003; Lanman et al., 2004). An additional suppressor,
I190V, mapped to the second CTD helix; a fourth fell in the cleavage site
separating CA and the downstream peptide.
This present study describes the isolation of two additional MHR
suppressors that lie on the dimerization helix. These, together with
the previously described I190V MHR suppressor, deﬁne an extended
region that overlaps the residues that are involved in subunit CTD–
CTD dimerization. The position of the MHR suppressors in CA as
well as the broad-spectrum nature of suppression argues that the
mutations likely work by controlling conformation of the protein. This
is further supported by the temperature-sensitive growth of some of
the mutants. These ﬁndings provide important biological evidence in
support of a major structural change in the CA CTD involving the MHR
and the α-2 helix such as that described by Ivanov et al. during the
maturation and assembly of the functional core.
Results and discussion
MHR mutants are rescued by second-site mutations in the α-2 helix of
the CTD
In the ﬁrstMHR suppressor hunt, three substitutions in the α-helical
portion of the MHR yielded four suppressors located in distant regions
of the CA protein structure (Bowzard et al., 2001). To assess whether ornot MHR mutations that lie in structurally distinct locations can be
corrected by a similar array of secondary changes, we have since sought
second-site suppressors of a D155Y mutation (which lies on the strand
at the upstream boundary of the MHR) and an E162Q substitution
(immediately preceding the α-helix, contributing to the H-bonding
network in the domain) (Fig. 1B). Both the D155Yand E162Qmutations
allow release of particles that exhibit defects in core integrity (Cairns
and Craven, 2001). D155Yand E162Q revertant viruses were isolated by
introducing proviral plasmids bearing the MHR mutations into turkey
embryo ﬁbroblasts by transfection to allow synthesis of the crippled
viruses, and thesewere allowed to evolve during several weeks of serial
passages (Bowzard et al., 2001). Periodic sampling of the culture
medium detected a rise in reverse transcriptase activity indicative of a
reversion event. Sequences containing the original MHR mutations
were detected in the genomic DNA of each culture and, in addition, a
novel mutation was detected in each (R185W in the D155Y culture and
F193L in the E162Q culture).
Each of the two suspect suppressors was recreated in a GFP-coding
proviral vector in combination with the MHR mutation with which it
had evolved and also in an otherwise wild-type (WT) plasmid. The
potential of each to suppress the MHR mutation was assessed in DF1
(chicken) cells at 37 °C, monitoring the spread of virus through the cell
population by ﬂow cytometry to detect GFP expression (Fig. 2A, B). The
growth rate of each single- and double-mutant virus was calculated
from the exponential phase of GFP spread (Table 1)(Wang and
Bushman, 2006). Under these assay conditions, growth of virus bear-
ing the single D155Y MHR mutation was undetectable, i.e. indis-
tinguishable from mock-infected cultures. However, the infectivity
was restored to half that of the WT virus by addition of the R185W
mutation (Fig. 2A). Similarly, the very sluggish growth of E162Q virus
(about one-tenth that of the WT virus) was reversed to within half of
the WT growth rate by the second-site F193L substitution (Fig. 2B).
Thus, both newly identiﬁed CA mutations have suppressor activity.
Fig. 3. Rescue of the MHR mutants by the suppressor mutations is not allele-speciﬁc.
Viral growth kinetics of allele-swapped double-mutant viruses was measured as in
Fig. 2. (A) The E162QMHRmutation in combinationwith various suppressor mutations.
(B) The F167Y MHR mutation in combination with various suppressor mutations.
Table 1
The viral growth kinetics of the single- and double-mutant viruses
Substitutions in the MHR
WT D155Y E162Q F167Y L171V
Secondary
mutations
in CA
WT ++++ − − − −
1.03±0.05 b0.05 0.08±0.09 0.08±0.02 b0.05
R185W +++ − +++ ++++ −
0.83±0.08 0.56±0.05 0.70±0.15 1.01±0.03 b0.05
F193L +++ − ++ − −
0.75±0.03 b0.05 0.60±0.07 b0.05 b0.05
I190V +++ − + +++ −
0.76±0.02 0.05±0.04 0.21±0.10 0.92±0.02 b0.05
A38V +++ − − +++ ++
0.68±0.01 b0.05 b0.05 0.71±0.04 0.54±0.05
Mean growth rate and standard deviation for each of the viruses was calculated from at
least three independent experiments as described by Wang and Bushman (Wang and
Bushman, 2006). Viral infectivity of each mutant was then compared to the wild-type
virus, and expressed by the following symbols: “++++” N90% of the WT virus, “+++” 65–
90% of theWT virus, “++” 40–65% of the WT virus, “+” 15–40% of the WT virus, “−” b15%
of the WT virus.
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as was documented for the previously published MHR suppressors.
The R185W and the F193L suppressors lie on the α-2 helix of the
CTD, one on either side of the I190V suppressor that was originally
described as a suppressor of the crippling F167Y MHR mutation. This
helix is well documented to serve a critical role in capsid assembly as
the principal site of CTD–CTD dimerization in themature capsid shell. It
has also been implicated in Gag protein dimerization (Datta et al., 2007;
Ivanov et al., 2005, 2007). A fourthmutation, C192R, described by Spidel
et al. as a suppressor of a β-hairpin mutation (K5R) in the NTD of RSV
CA, falls within the same region of the α-2 helix. Thus, we have
identiﬁed a cluster (“hot-spot”) of four suppressors along this helix.
A structure of the mature, dimerized CTD of RSV has not been
published as yet. However, it was possible to examine the relationship
of the residues involved in suppression to the presumed interface by
utilizing a model of the RSV CTD dimer based upon the well-
established HIV-1 CTD dimer structure (R. Kingston, pers. comm.)
(Fig. 1C). The RSV CTD dimer model was generated by aligning the
structure of the RSV CTD (PDB ﬁle E1OQ) and the HIV-1 CTD dimer
(PDB ﬁle 1A43) using SARF2 program, which only generated one
solution due to similarity in the length and orientation of the helices
in the two structures (Alexandrov and Fischer, 1996; Kingston et al.,
2000;Worthylake et al., 1999). In the model of the RSV CTD dimer, it is
clear that the F193, I190 and R185 residues span the region that is
likely to be involved directly in the dimer interface but are unlikely to
participate in the interface. Rather, the side-chains of each point away
from the predicted interface with F193 buried in the hydrophobic core
of the CTD, while I190 and R185 are more exposed. Furthermore,
examination of the published model for the CTDmonomer shows that
none of the MHR residues are situated in a position that would place
their side-chains in the proximity of the residues responsible for
suppression. Preliminary attempts to model the RSV CTD protein upon
the proposed immature HIV-1 CTD dimer (Ivanov et al., 2007) were
unsuccessful due to limited amino acid similarity between the two
proteins outside of the MHR, but a comprehensive computational
study has not been conducted. However, in the immature HIV-1 CTD
dimer model, the side-chains of the MHR residues and the side-chains
of the residues corresponding to the RSV suppressors were not in close
vicinity (Ivanov et al., 2007). This argues that the second-site sup-
pressors do not act bymaking direct contact with the MHR residues or
by directly affecting the CTD–CTD dimerization interface. The R185W
residue, in contrast to the other nearby suppressors, is located nearthe top of the dimerization helix. The analogous position in the HIV
protein is involved directly in the NTD–CTD interface, raising the
possibility that suppression of the D155Y defect by R185W in RSV
involves strengthening of the inter-domain interface (Ganser-Pornil-
los et al., 2007; Lanman et al., 2003). No models of this interface in
assembled HIV CA are as yet of sufﬁcient resolution to allow the
modeling of the RSV interface to examine this interpretation more
carefully.
MHR mutations and suppressor mutations are not allele-speciﬁc
All theMHR suppressor mutations isolated lie close to or in regions
that have been implicated in the process of maturation of the virus
capsid, suggesting that compensation could be accomplished by
modulating protein conformation and/or the kinetics of the matura-
tion process. If so, then some degree of cross-suppression between
different alleles might be predicted. To test this, the infectivity of
mutant viruses bearing double mutations in various combinations
was measured. In addition to the three suppressors on the dimeriza-
tion helix, the L171V MHR mutation and its A38V suppressor in the
NTD were included to evaluate whether or not inter-domain
suppression is allele-speciﬁc. Table 1 compares the average growth
rate for each virus at 37 °C. The results for the mutants carrying a
single MHR mutation or either of the previously described suppres-
sors (I190V and A38V) are consistent with published infectivity data
obtained with turkey embryo ﬁbroblast cells using less quantitative
methodologies (Bowzard et al., 2001).
The pattern of suppression was found to vary depending upon the
MHR allele examined. The E162Q and F167Y mutations were each
effectively suppressed by more than one secondary mutation (Fig. 3A,
B). The growth defect of E162Q was corrected as readily by R185W as
it was by the original suppressor F193L (Fig. 3A). Suppression of
Fig. 4. Temperature-sensitivity of mutants. Viruses were tested for their growth kinetics
at 37 °C and 42 °C. (A) Temperature-sensitive phenotype of the E162Q/F193L and the
E162Q mutant. (B) Temperature-sensitive phenotype of the L171V/A38V and the A38V
mutant. (C) Temperature-sensitive phenotype of the F167Y/A38V and the F167Y
mutant.
Fig. 5. Budding of viruses from QT6 cells at 37 °C. The immuno-precipitated viral
proteins harvested from the lysates of cells labeled for 5 min (L) and from the media of
cells labeled for 2.5 h (M) were detected by autoradiography.
195P.M. Lokhandwala et al. / Virology 376 (2008) 191–198the E162Q phenotype by I190V was less effective but still readily
detectable. In contrast, the NTD substitution A38V not only failed to
suppress but actually ablated the weak infectivity of E162Q. The
growth-crippling F167Y MHR allele exhibited a unique suppression
pattern—it was strongly suppressed by R185W and the inter-domain
suppressor A38V but not at all by F193L (Fig. 3B). In fact, the F193L
secondary mutation eliminated the slight residual replication that is
characteristic of the F167Y single-mutant. In addition to A38V and
R185W, the replication defect in F167Y was also shown previously to
be suppressed by a single substitution S241L in the cleavage site at the
end of CA (Bowzard et al., 2001). Notably, the R185W substitution
(originally isolated as a suppressor of D155Y) was even more effective
in correcting the growth defects of E162Q and F167Y making it a
powerful broad-spectrum suppressor.
In sharp contrast to the above, the D155Y and L171V MHR sub-
stitutions, both of which cause a complete loss of detectable replication
at 37 °C,were resistant to correction byany secondary change other than
the original suppressor (R185Wand A38V, respectively, Table 1). This is
likely a reﬂection of the profound effects of these MHR mutations on
protein structure and virus replication. Since these same two suppres-
sors each have some broad-spectrum activity, it is clear that none of the
pairs of MHRmutations and suppressors thatwere originally associated
with them are truly speciﬁc for one another.Several mutants exhibit temperature-sensitivity
As might be expected of mutations that affect either folding path-
ways or protein conformation, some of the mutants exhibit tempera-
ture-sensitive growth. Those single- and double-mutants that showed
detectable growth at 37 °C were also screened for growth at 42 °C.
Three substitutions proved to have a temperature-dependent effect on
growth (the A38V suppressor in the NTD and the F167Y and E162Q
MHRmutations). The slowgrowth of the F167Yand E162Q viruseswas
completely inhibited by increasing the growth temperature at 42 °C,
whereas the elevated temperature had no deterrent effect on the
growth rate of WT virus (Fig. 4A, B). The E162Q/F193L, E162Q/R185W
and E162Q/I190V double-mutants were also temperature-sensitive
(Fig. 4A, data not shown), although viruses bearing the F193L, R185W,
or I190V suppressor without an MHR mutation were not. Thus, no
suppressor was able to counteract the temperature-sensitivity due
to E162Q. The NTD A38V substitution also caused a very strong
temperature-sensitive effect that was observed both in the context
of the single-mutant or in combination with either L171V or F167Y
(Fig. 4B, C).
When the E162Q/F193L, L171V/A38V or WT viruses produced at
37 °C (permissive temperature) were used to infect DF1 cells growing
at 37 °C and at 42 °C and the percent infected cells weremeasured 24 h
post-infection, it was noted that a reproducibly higher percentage of
cells were infected when the target cells were growing at 42 °C than at
37 °C. Similar result was also obtained when the viruses were
produced at 42 °C. This argues that the temperature-sensitive growth
of these viruses is not due to the effect of temperature on the early
steps of the virus life-cycle (i.e. virus attachment, entry, reverse-
transcription, nuclear entry, integration or expression).
Finally, of the four MHR mutations examined above only E162Q
causes a detectable effect on Gag function—the efﬁciency of virus
assembly and release at 37 °C is diminished to ~60% that of the WT in
QT6 cells (Cairns and Craven, 2001)(Fig. 5). This reduced particle release
was restored to normal by the F193L suppressor indicating that at least
some of the replicationdeﬁcit in E162Q is due to effects onGag assembly
function (Fig. 5). When the virus release in two independent experi-
ments was normalized for the amount of expression, the budding
efﬁciency at 37 °Cwas calculated to be 54% for E162Q, 87% for F193L and
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could improve the budding efﬁciency of the E162Q virus, it could not
rescue the infectivity of the virus at 42 °C, suggesting the presence of an
additional defect presumably during core maturation.
Implications
The retroviral CA protein is a dynamic protein that possesses a
dramatic ﬂexibility in the range of intermolecular interactions it forms
and in the ability of the individual domains to change conformations
upon cleavage, mutations or binding of various molecules (Alcaraz
et al., 2007; Barrera et al., 2006; Berthet-Colominas et al.,1999; Gamble
et al., 1997; Gross et al., 2000; Jin et al., 1999; Nandhagopal et al., 2004;
Ternois et al., 2005; von Schwedler et al.,1998;Worthylake et al.,1999).
Both the inherent intra-domain ﬂexibility and ﬂexibility in inter-
molecular contacts are likely to be critical to the ability to form a capsid
shell (Ganser-Pornillos et al., 2007; Li et al., 2000). Furthermore, the
ability of the CA to successfully undergo the dynamic events needed to
support different functions at different points in the replication cycle
almost certainly requires a balancing of various structural constraints
that has been ﬁnely tuned through evolution. Our data suggest that the
MHR and the dimerization helix modulate conformational changes
during maturation.
Genetic screens for second-site suppressor mutations have proven a
useful tool to identify distant regions of CA that cooperate to control the
conformation changes and/or binding events that are needed to build a
functional capsid. The clustering of four suppressormutations along the
dimerization helix indicates that, in addition to serving as a primary
point of contact between CTDs in the mature capsid, this helix as a
whole is probably a site of signiﬁcant conformational change during
maturation. Furthermore, it appears to work in cooperation with the
MHR to control the ability of the CTD to achieve an assembly-competent
conformation during maturation. This is supported by the fact that
some of the MHR mutations (F167Y, L171V and D155Y) disrupt the
ability of the RSV CA protein to assemble in vitro into capsid-like
structures, while the corresponding suppressors rescue this phenotype
(Purdy et al., in press). Further, it suggests that MHR mutations are
lethal due to effects on the conformation of the following helix, a
prediction that is currently being tested by our laboratory. Control of the
α-2 conformation by the MHR residues and their suppressors is
supported by both the broad-spectrum suppression exhibited by three
secondary substitutions (R185W, I190V and A38V) and by temperature-
sensitivity in case of E162Q and F167Y. Importantly, these mutations
provide biological evidence in support of the suggestion that the
formation of a slight kink in the helix (exactly overlapping I190 and
F193) during maturation may be crucial to the ability of the protein to
achieve assembly-competence (Campos-Olivas et al., 2000; Ivanov et
al., 2007; Khorasanizadeh et al., 1999; Kingston et al., 2000).
The R185W suppressor lies in a positionwhere, in addition to poten-
tially affecting α-2 conformation, it may act by directly modulating the
formation of the NTD–CTD interface (Ganser-Pornillos et al., 2007;
Lanmanet al., 2003). TwoMHRsuppressorswerepreviously described in
theNTD. One of these (P65Q at the base of α-4 NTD helix) is predicted to
participate directly in the inter-domain interface. A38V, however, is not
expected to participate directly in interfaces but does lie within a region
(α-2 helix in the NTD) where it could induce conformational effects that
could affect NTD multimerization and the ability of the NTD to form
inter-domain interactions (Ganser-Pornillos et al., 2007; Mortuza et al.,
2004). Again, such a mode of action is supported by both its ability to
suppress two different MHR alleles and by its temperature-sensitivity.
The promiscuous suppression of F167Y by four different secondary
mutations that alter the CTD, the NTD, or the rate of proteolytic
cleavage of the downstream spacer-peptide from the C-terminus of
the CA is particularly intriguing. In the proposed immature interface,
this residue participates in a hydrophobic interaction across the
interface, but upon maturation it must move into an internal positionwithin the CTD core. We suggest that the F167Y substitution, which is
tolerated by Gag during immature assembly, cripples normal core
formation by affecting the propensity of the domain to proceed
normally through the conformational and folding changes that are
triggered by proteolytic processing. The same interpretation could
apply to the L171V substitution that lies one turn of the helix past
F167Y at the immature dimer interface. The suppression of F167Y by
secondary changes in two different domains suggests that compensa-
tion for a limited representation of the assembly-competent CTD
conformation in a population of folding intermediates might be
accomplished by either a secondary change in the α-2 helix or by
contact between the α-2 helix and the NTD that could stabilize the
proper conformation. A role for binding-induced conformational
changes (induced ﬁt) in forming the NTD–CTD and CTD–CTD interfaces
has been suggested (Ganser-Pornillos et al., 2007; Mateu, 2002).
In summary, the phenotypes of the mutations presented provide
support for a model of core maturation in which the MHR and α-2
helix undergo signiﬁcant rearrangement during maturation, such as
that proposed by Ivanov et al. (Ivanov et al., 2007). Because of the
documented relevance of retrovirus maturation inhibitors as a viable
approach for antiviral therapy, understanding the molecular details of
maturation is critical. The MHR mutations and suppressors provide a
useful tool to be utilized in deﬁning the important transient inter-
mediates of maturation, as well as providing an important means for
evaluating the validity of developing models of core assembly.
Materials and methods
Proviral genomes
Proviral plasmid pRC.V8, which was used for revertant virus
isolation, was derived from an RCAN plasmid by replacement of the
Schmidt–RuppinA gag genewith that of Prague C. Identiﬁedmutations
were then engineered into pRS.V8.eGFP, an analogous splicing-
competent plasmid encoding eGFP (Callahan and Wills, 2003). To
create the R185Wsubstitution, codons 185 and186were changed from
CGGGCT to TGGGCA which also created an additional silent mutation
destroying the adjacent BanII site. The F193L was produced by
changing codon 193 from TTT to TTA, which also created a novel AﬂII
site. The D155Y, E162Q, F167Y, L171V, I190V and A38Vmutations have
previously been described (Bowzard et al., 2000; Cairns and Craven,
2001). The various single and double mutations were engineered into
the pRS.V8.eGFP plasmid by either oligonucleotide-directedmutagen-
esis and/or by restriction fragment exchange to create various
combinations of mutations, and conﬁrmed by sequencing.
Identiﬁcation of second-site suppressor mutations
Primary turkey embryo ﬁbroblast cultures were transfected with
either the E162Q or D155Y mutant proviral genome and serially
passaged for 24 days. Genomic DNA was extracted from the cultures
that showed a marked increase in extracellular reverse transcriptase
over this time-frame and the gag region was PCR-ampliﬁed and
sequenced to identify the novel mutations.
Infectivity experiments and growth rates
QT6 (transformed quail) cells were transfected with pRS.V8.eGFP
genomes to produce suspensions of WT or mutant viruses, which
were then normalized by exogenous reverse transcriptase assay and
used to infect DF1 (chicken ﬁbroblast) cells. The fraction of cells that
were expressing GFP were measured by ﬂow cytometry at various
times post-infection (Spidel et al., 2004). Eachmutant was analyzed in
at least three independent experiments. Two independently derived
clones were tested for each of the mutants, except for the E162Q/
F193L and the previously published F167Y, I190V and F167Y/I190V
197P.M. Lokhandwala et al. / Virology 376 (2008) 191–198viruses, where a single clone was tested several times. Growth rates
were computed for each virus as described previously (Wang and
Bushman, 2006). Brieﬂy, data from each culture was plotted as ln (%
green cells) versus time, and the exponential phase for each growth
curve was identiﬁed by visual examination of the data. The slope of
the line, ﬁt by linear regression to the exponential phase for each
curve, was calculated using GraphPad Prism 4 software. This slopewas
expressed as the growth rate in units of ln(% infected cells)/time. Mean
and standard deviation for each mutant was calculated by combining
data from several independent experiments and presented in Table 1.
For certain non-infectious mutants, the values for percent GFP-ex-
pressing cells were usually below 0.1%, which we have set opera-
tionally as our background detection limit. This prevented us from
accurately ﬁtting a linear-exponential model. The growth rates of such
non-infectious mutants were assigned a value of b0.05.
Testing the temperature-sensitivity of the viruses
To test the effect of temperature on the virus infectivity, WT and
mutant viruses were produced from transfected QT6 cells at 37 °C and
at 42 °C. All virus preps produced at 37 °C were normalized to each
other and used to infect DF1 cells at 37 °C. Similarly viruses produced
at 42 °C were normalized and used to infect DF1 cells at 42 °C. Spread
of virus in the cultures was detected as mentioned above.
Testing the budding efﬁciency of viruses
The budding efﬁciency of the viruses was measured as described
previously (Cairns and Craven, 2001). Brieﬂy, duplicate plates of QT6 cells
growing at 37 °C were transfected with WT or mutant pRS.V8.eGFP
genomes, and at 24 h post-transfection the cells were radiolabelled with
[35S]-methionine (50 μCi,1000Ci/mmol). Cells fromone setof plateswere
lysed after 10 min to examine Gag expression, while the extracellular
viruses were harvested from a second set of plates that were labeled
for 2.5 h. The viral proteins from the cell lysates and the media samples
were immuno-precipitated using a polyclonal anti-RSV serum and
subjected to SDS-polyacrylamide gel electrophoresis, followed by
autoradiography. Budding efﬁciency for each virus was measured by
calculating the ratio of the CAprotein found inmedia samples to the level
of Gag protein in the cell lysates and expressed as a percentage of theWT
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